SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations.” Granite Record, https://graniterecord.org/bill/2022/sb374. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2022/sb374
- Chicago
- Granite Record. “SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2022/sb374.
- BibTeX
@misc{bill-2022-sb374, title = {SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2022/sb374}, note = {Accessed 24 Oct. 2026} }
SB 374-FN (2022)
relative to the SARS-CoV-2 vaccinations.
- Status: Referred for interim study
- Term: 2021-2022
- Senate committee: Health and Human Services
- Subject: Miscellaneous
The Story
It was introduced on January 5, 2022 and referred to the Senate Health and Human Services committee. The committee held a public hearing on February 9, 2022. The committee recommended that the Senate study it after the session ends. On March 17, 2022 the Senate adopted “Refer to Interim Study, RC 18Y-6N”.
Sponsors
- Sen. Harold French (R - SD7) (prime sponsor)
- Sen. Kevin Avard (R - SD12)
- Rep. Gregory Hill (R - Merr 3)
- Rep. Gregg Hough (R - Belk 3)
- Rep. Norman Silber (R - Belk 2)
Hearings and Sessions
- February 9, 2022, 10:30 AM: hearing, Senate Health and Human Services, SH 100
Votes
- March 17, 2022, Senate: Interim Study — yeas 18, nays 6, passed
The Docket
- January 5, 2022: To Be Introduced 01/05/2022 and Referred to Health and Human Services
- February 9, 2022: Hearing: 02/09/2022, Room 100, SH, 10:30 am
- March 17, 2022: Committee Report: Referred to Interim Study, 03/17/2022
- March 17, 2022: Refer to Interim Study, RC 18Y-6N, MA; 03/17/2022